Leukemia Research
Volume 30, Issue 4 , Pages 449-457, April 2006

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma

  • Catherine A. Tucker

      Affiliations

    • The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    • The Department of Pathology and Laboratory Medicine at the University of British Columbia, Vancouver, BC, Canada
    • Corresponding Author InformationCorresponding author. Tel.: +1 604 675 8000/7025; fax: +1 604 675 8183.
    • ,
  • Gwyn Bebb

      Affiliations

    • The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Richard J. Klasa

      Affiliations

    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Mukesh Chhanabhai

      Affiliations

    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Valia Lestou

      Affiliations

    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Douglas E. Horsman

      Affiliations

    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Randy D. Gascoyne

      Affiliations

    • Divisions of Medical Oncology and Pathology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • ,
  • Adrian Wiestner

      Affiliations

    • Metabolism Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA
    • ,
  • Dana Masin

      Affiliations

    • The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    • ,
  • Marcel Bally

      Affiliations

    • The Department of Advanced Therapeutics, BC Cancer Research Center, 675 West 10th Avenue, 5th Floor, Vancouver, BC, Canada
    • The Department of Pathology and Laboratory Medicine at the University of British Columbia, Vancouver, BC, Canada
    • ,
  • Michael E. Williams

      Affiliations

    • Hematology/Oncology Division and Hematologic Malignancy Program, University of Virginia Cancer Center and School of Medicine, Charlottesville, VA, USA

Received 21 April 2005; received in revised form 11 August 2005; accepted 12 August 2005. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(05)00323-1

doi:10.1016/j.leukres.2005.08.016

Leukemia Research
Volume 30, Issue 4 , Pages 449-457, April 2006

Article Tools

* Image Usage & Resolution